BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Popat A, Jambhrunkar S, Zhang J, Yang J, Zhang H, Meka A, Yu C. Programmable drug release using bioresponsive mesoporous silica nanoparticles for site-specific oral drug delivery. Chem Commun (Camb) 2014;50:5547-50. [PMID: 24603852 DOI: 10.1039/c4cc00620h] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 9.1] [Reference Citation Analysis]
Number Citing Articles
1 Ren M, Li N, Jiang X, Liu X, Zou A. Efficient oral delivery of water-soluble CT contrast agent using an W1/O/W2 alginate hydrogel matrix. Colloids and Surfaces B: Biointerfaces 2022;220:112862. [DOI: 10.1016/j.colsurfb.2022.112862] [Reference Citation Analysis]
2 Niu Y, Yang Y, Yang Z, Wang X, Zhang P, Lv L, Liu Y, Liu Y, Zhou Y. Aptamer-immobilized bone-targeting nanoparticles in situ reduce sclerostin for osteoporosis treatment. Nano Today 2022;45:101529. [DOI: 10.1016/j.nantod.2022.101529] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Eleftheriadis GK, Kontogiannidou E, Karavasili C, Fatouros DG. Strategies for MR Formulation Development. Oral Drug Delivery for Modified Release Formulations 2022. [DOI: 10.1002/9781119772729.ch9] [Reference Citation Analysis]
4 Poyatos-Racionero E, González-Álvarez I, Sánchez-Moreno P, Sitia L, Gatto F, Pompa PP, Aznar E, González-Álvarez M, Martínez-Máñez R, Marcos MD, Bernardos A. Lactose-Gated Mesoporous Silica Particles for Intestinal Controlled Delivery of Essential Oil Components: An In Vitro and In Vivo Study. Pharmaceutics 2021;13:982. [PMID: 34209675 DOI: 10.3390/pharmaceutics13070982] [Reference Citation Analysis]
5 Poyatos-Racionero E, Guarí-Borràs G, Ruiz-Rico M, Morellá-Aucejo Á, Aznar E, Barat JM, Martínez-Máñez R, Marcos MD, Bernardos A. Towards the Enhancement of Essential Oil Components' Antimicrobial Activity Using New Zein Protein-Gated Mesoporous Silica Microdevices. Int J Mol Sci 2021;22:3795. [PMID: 33917595 DOI: 10.3390/ijms22073795] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
6 Uday Patel A, Dipakbhai Solanki P. Functionalized MCM-48 as Carrier for In Vitro Controlled Release of an Active Biomolecule, L-Arginine. Advances in Microporous and Mesoporous Materials 2020. [DOI: 10.5772/intechopen.90175] [Reference Citation Analysis]
7 Nasr SS, Nasra MMA, Hazzah HA, Abdallah OY. Mesoporous silica nanoparticles, a safe option for silymarin delivery: preparation, characterization, and in vivo evaluation. Drug Deliv Transl Res 2019;9:968-79. [PMID: 31001719 DOI: 10.1007/s13346-019-00640-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
8 Pereira de Sousa I, Gourmel C, Berkovska O, Burger M, Leroux J. A microparticulate based formulation to protect therapeutic enzymes from proteolytic digestion: phenylalanine ammonia lyase as case study. Sci Rep 2020;10. [DOI: 10.1038/s41598-020-60463-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
9 Chou W, Lühmann T, Meinel L, Morales JO. Nanoparticle Design to Improve Transport Across the Intestinal Barrier. Nanopharmaceuticals: Principles and Applications Vol. 3 2020. [DOI: 10.1007/978-3-030-47120-0_9] [Reference Citation Analysis]
10 Abeer MM, Meka AK, Pujara N, Kumeria T, Strounina E, Nunes R, Costa A, Sarmento B, Hasnain SZ, Ross BP, Popat A. Rationally Designed Dendritic Silica Nanoparticles for Oral Delivery of Exenatide. Pharmaceutics 2019;11:E418. [PMID: 31430872 DOI: 10.3390/pharmaceutics11080418] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 11.7] [Reference Citation Analysis]
11 Kesse S, Boakye-Yiadom KO, Ochete BO, Opoku-Damoah Y, Akhtar F, Filli MS, Asim Farooq M, Aquib M, Maviah Mily BJ, Murtaza G, Wang B. Mesoporous Silica Nanomaterials: Versatile Nanocarriers for Cancer Theranostics and Drug and Gene Delivery. Pharmaceutics 2019;11:E77. [PMID: 30781850 DOI: 10.3390/pharmaceutics11020077] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 16.3] [Reference Citation Analysis]
12 Ferri D, Gaviña P, Parra M, Costero AM, El Haskouri J, Amorós P, Merino V, Teruel AH, Sancenón F, Martínez-Máñez R. Mesoporous silica microparticles gated with a bulky azo derivative for the controlled release of dyes/drugs in colon. R Soc Open Sci 2018;5:180873. [PMID: 30225077 DOI: 10.1098/rsos.180873] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
13 Gonçalves MC. Sol-gel Silica Nanoparticles in Medicine: A Natural Choice. Design, Synthesis and Products. Molecules 2018;23:E2021. [PMID: 30104542 DOI: 10.3390/molecules23082021] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 16.0] [Reference Citation Analysis]
14 Mariano-neto F, Cides da Silva LC, Oliveira CLP, Fantini MCA. Vacuum Calcination Behavior of SBA-15 Ordered Mesoporous Silica. Braz J Phys 2018;48:442-50. [DOI: 10.1007/s13538-018-0579-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Solanki P, Patel A. In vitro release of l-arginine and cysteine from MCM-48: a study on effect of size of active biomolecules on release rate. J Porous Mater 2018;25:1489-98. [DOI: 10.1007/s10934-018-0561-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Diab R, Canilho N, Pavel IA, Haffner FB, Girardon M, Pasc A. Silica-based systems for oral delivery of drugs, macromolecules and cells. Adv Colloid Interface Sci 2017;249:346-62. [PMID: 28473052 DOI: 10.1016/j.cis.2017.04.005] [Cited by in Crossref: 83] [Cited by in F6Publishing: 86] [Article Influence: 16.6] [Reference Citation Analysis]
17 Albert K, Huang XC, Hsu HY. Bio-templated silica composites for next-generation biomedical applications. Adv Colloid Interface Sci 2017;249:272-89. [PMID: 28499603 DOI: 10.1016/j.cis.2017.04.011] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 7.2] [Reference Citation Analysis]
18 Liu F, Qin X, Xiao D, Dai X, Peng X, Chen T. Towards site-specific nanoparticles for drug delivery application: preparation, characterization and release performance. Chem Pap 2017;71:2385-94. [DOI: 10.1007/s11696-017-0233-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
19 Wang R, Zhou L, Wang W, Li X, Zhang F. In vivo gastrointestinal drug-release monitoring through second near-infrared window fluorescent bioimaging with orally delivered microcarriers. Nat Commun 2017;8:14702. [PMID: 28281530 DOI: 10.1038/ncomms14702] [Cited by in Crossref: 164] [Cited by in F6Publishing: 170] [Article Influence: 32.8] [Reference Citation Analysis]
20 Gisbert-Garzarán M, Manzano M, Vallet-Regí M. pH-Responsive Mesoporous Silica and Carbon Nanoparticles for Drug Delivery. Bioengineering (Basel) 2017;4:E3. [PMID: 28952481 DOI: 10.3390/bioengineering4010003] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 9.2] [Reference Citation Analysis]
21 Shen S, Dong Y, Letchmanan K, Ng WK. Mesoporous materials and technologies for development of oral medicine. Nanostructures for Oral Medicine. Elsevier; 2017. pp. 699-749. [DOI: 10.1016/b978-0-323-47720-8.00024-9] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
22 Bhat IUH, Khanam Z, Bhat A. Current Trends in the Preparation of Nanoparticles for Drug Delivery. Engineering Applications of Nanotechnology 2017. [DOI: 10.1007/978-3-319-29761-3_12] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
23 Zong W, Hu Y, Su Y, Luo N, Zhang X, Li Q, Han X. Polydopamine-coated liposomes as pH-sensitive anticancer drug carriers. Journal of Microencapsulation 2016;33:257-62. [DOI: 10.3109/02652048.2016.1156176] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 8.0] [Reference Citation Analysis]
24 Bhat R, Ribes À, Mas N, Aznar E, Sancenón F, Marcos MD, Murguía JR, Venkataraman A, Martínez-máñez R. Thrombin-Responsive Gated Silica Mesoporous Nanoparticles As Coagulation Regulators. Langmuir 2016;32:1195-200. [DOI: 10.1021/acs.langmuir.5b04038] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
25 Desai D, Prabhakar N, Mamaeva V, Karaman DŞ, Lähdeniemi IA, Sahlgren C, Rosenholm JM, Toivola DM. Targeted modulation of cell differentiation in distinct regions of the gastrointestinal tract via oral administration of differently PEG-PEI functionalized mesoporous silica nanoparticles. Int J Nanomedicine 2016;11:299-313. [PMID: 26855569 DOI: 10.2147/IJN.S94013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
26 Aznar E, Oroval M, Pascual L, Murguía JR, Martínez-máñez R, Sancenón F. Gated Materials for On-Command Release of Guest Molecules. Chem Rev 2016;116:561-718. [DOI: 10.1021/acs.chemrev.5b00456] [Cited by in Crossref: 371] [Cited by in F6Publishing: 360] [Article Influence: 61.8] [Reference Citation Analysis]
27 Fox CB, Kim J, Le LV, Nemeth CL, Chirra HD, Desai TA. Micro/nanofabricated platforms for oral drug delivery. J Control Release 2015;219:431-44. [PMID: 26244713 DOI: 10.1016/j.jconrel.2015.07.033] [Cited by in Crossref: 70] [Cited by in F6Publishing: 60] [Article Influence: 10.0] [Reference Citation Analysis]
28 Kim S, Canilho N, Pasc A. Stimuli-Responsive Nanostructured Silica Matrix Targeting Drug Delivery Applications. Biological and Pharmaceutical Applications of Nanomaterials 2015. [DOI: 10.1201/b18654-3] [Reference Citation Analysis]